See more : Natural Biocon (India) Limited (NATURAL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Riso Kyoiku Co., Ltd. (4714.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Riso Kyoiku Co., Ltd., a leading company in the Education & Training Services industry within the Consumer Defensive sector.
- Silver Elephant Mining Corp. (SILEF) Income Statement Analysis – Financial Results
- Universal Corporation (UVV) Income Statement Analysis – Financial Results
- Sichuan Xichang Electric Power Co.,Ltd. (600505.SS) Income Statement Analysis – Financial Results
- freenet AG (FNTN.HM) Income Statement Analysis – Financial Results
- AS PARTNERS CO LTD (160A.T) Income Statement Analysis – Financial Results
Riso Kyoiku Co., Ltd. (4714.T)
Industry: Education & Training Services
Sector: Consumer Defensive
Website: https://www.riso-kyoikugroup.com
About Riso Kyoiku Co., Ltd.
Riso Kyoiku Co., Ltd. operates TOMAS private study Juku schools for elementary, and junior and senior high school students in Japan. The company also operates MEDIC TOMAS private study Juku schools that specialize in preparation for medical school exams. It operates 64 TOMAS private study Juku schools. Riso Kyoiku Co., Ltd. was founded in 1985 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 32.22B | 31.49B | 30.01B | 25.20B | 26.70B | 24.50B | 22.58B | 20.78B | 19.64B | 18.78B | 19.78B | 21.79B | 20.15B | 18.75B | 17.35B | 16.31B |
Cost of Revenue | 23.70B | 22.98B | 21.55B | 19.10B | 19.00B | 17.38B | 16.24B | 15.07B | 14.35B | 14.56B | 15.95B | 14.57B | 13.18B | 12.09B | 10.89B | 10.65B |
Gross Profit | 8.52B | 8.51B | 8.46B | 6.11B | 7.71B | 7.11B | 6.34B | 5.70B | 5.29B | 4.22B | 3.83B | 7.22B | 6.97B | 6.66B | 6.46B | 5.66B |
Gross Profit Ratio | 26.44% | 27.02% | 28.19% | 24.23% | 28.86% | 29.04% | 28.08% | 27.46% | 26.94% | 22.47% | 19.35% | 33.14% | 34.60% | 35.50% | 37.21% | 34.70% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.40B | 4.44B | 5.43B | 5.09B | 4.99B | 4.58B | 4.18B | 3.65B | 3.40B | 3.21B | 4.33B | 4.45B | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 1.42B | 1.57B | 1.44B | 1.27B | 1.37B | 1.22B | 1.09B | 907.00M | 898.00M | 771.00M | 1.61B | 1.79B | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.93B | 6.01B | 5.43B | 5.09B | 4.99B | 4.58B | 4.18B | 3.65B | 3.40B | 3.21B | 4.33B | 4.45B | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 105.00M | 37.22M | 58.11M | 210.82M | 32.79M | 6.42M | 4.42M | 12.16M | 12.11M | 10.73M | 9.27M | 7.73M | 9.06M | 17.00M | 16.32M | 6.75M |
Operating Expenses | 5.93B | 6.11B | 5.43B | 5.09B | 4.99B | 4.58B | 4.18B | 3.65B | 3.40B | 3.21B | 4.33B | 4.45B | 4.16B | 3.96B | 3.91B | 3.95B |
Cost & Expenses | 29.63B | 29.09B | 26.98B | 24.19B | 23.99B | 21.97B | 20.43B | 18.73B | 17.75B | 17.77B | 20.28B | 19.02B | 17.34B | 16.06B | 14.80B | 14.59B |
Interest Income | 25.00K | 25.00K | 26.00K | 1.15M | 25.00K | 20.00K | 32.00K | 49.00K | 1.26M | 12.04M | 258.00K | 304.00K | 223.00K | 374.00K | 672.00K | 17.76M |
Interest Expense | 555.00K | 29.00K | 1.91M | 2.12M | 95.00K | 27.00K | 370.00K | 59.00K | 201.00K | 16.41M | 28.76M | 38.71M | 45.21M | 48.20M | 55.09M | 59.27M |
Depreciation & Amortization | 496.84M | 412.63M | 366.88M | 356.89M | 312.98M | 271.57M | 263.97M | 239.54M | 215.97M | 201.47M | 334.55M | 210.12M | 243.35M | 337.79M | 290.37M | 324.50M |
EBITDA | 2.87B | 2.73B | 3.40B | 1.41B | 2.96B | 2.77B | 2.28B | 2.11B | 2.44B | 3.61B | -2.44B | 1.10B | 2.78B | 2.81B | 2.84B | 1.62B |
EBITDA Ratio | 8.90% | 9.13% | 11.43% | 6.00% | 11.40% | 11.41% | 10.51% | 10.78% | 10.56% | 11.28% | -2.25% | 13.65% | 15.19% | 16.26% | 16.44% | 12.64% |
Operating Income | 2.59B | 2.40B | 3.03B | 1.01B | 2.72B | 2.53B | 2.16B | 2.05B | 1.89B | 1.01B | -508.69M | 2.77B | 2.81B | 2.69B | 2.54B | 1.71B |
Operating Income Ratio | 8.03% | 7.63% | 10.10% | 4.01% | 10.17% | 10.33% | 9.56% | 9.87% | 9.62% | 5.36% | -2.57% | 12.70% | 13.93% | 14.37% | 14.67% | 10.50% |
Total Other Income/Expenses | -158.42M | -71.82M | 77.48M | 145.99M | -70.90M | -33.23M | -138.02M | -184.41M | 282.46M | 2.34B | -2.31B | 2.02B | -315.96M | -268.77M | -49.45M | -472.27M |
Income Before Tax | 2.43B | 2.33B | 3.11B | 1.16B | 2.65B | 2.50B | 2.02B | 1.87B | 2.17B | 3.35B | -2.82B | 2.82B | 2.49B | 2.43B | 2.49B | 1.24B |
Income Before Tax Ratio | 7.54% | 7.40% | 10.36% | 4.59% | 9.91% | 10.19% | 8.95% | 8.99% | 11.06% | 17.85% | -14.27% | 12.93% | 12.36% | 12.93% | 14.38% | 7.60% |
Income Tax Expense | 724.80M | 837.00M | 676.26M | 640.65M | 702.12M | 920.44M | 638.56M | 591.58M | 744.36M | 971.07M | -139.86M | 1.29B | 1.20B | 1.06B | 1.12B | 578.31M |
Net Income | 1.70B | 1.49B | 2.43B | 555.23M | 1.95B | 1.58B | 1.38B | 1.28B | 1.43B | 2.38B | -2.68B | 1.53B | 1.30B | 1.37B | 1.37B | 661.48M |
Net Income Ratio | 5.29% | 4.74% | 8.10% | 2.20% | 7.32% | 6.43% | 6.12% | 6.14% | 7.27% | 12.67% | -13.57% | 7.01% | 6.43% | 7.29% | 7.91% | 4.06% |
EPS | 11.04 | 9.67 | 16.25 | 3.79 | 13.24 | 10.68 | 9.36 | 8.37 | 9.23 | 15.94 | -20.13 | 1.82 | 12.19 | 12.52 | 12.28 | 5.59 |
EPS Diluted | 11.01 | 9.65 | 16.22 | 3.79 | 13.23 | 10.68 | 9.36 | 8.37 | 9.23 | 15.94 | -20.13 | 1.81 | 12.19 | 12.52 | 12.28 | 5.59 |
Weighted Avg Shares Out | 154.36M | 154.33M | 149.67M | 146.39M | 147.60M | 147.63M | 147.63M | 152.31M | 154.75M | 149.32M | 133.26M | 108.09M | 106.21M | 109.18M | 111.74M | 118.29M |
Weighted Avg Shares Out (Dil) | 154.72M | 154.65M | 149.90M | 146.54M | 147.70M | 147.63M | 147.63M | 152.31M | 154.75M | 149.32M | 133.26M | 108.25M | 106.21M | 109.18M | 111.74M | 118.29M |
Source: https://incomestatements.info
Category: Stock Reports